| Literature DB >> 32346518 |
Alice Arndt1, Julian Rubel2, Thomas Berger3, Wolfgang Lutz1.
Abstract
OBJECTIVE: While adherence is an important factor influencing the effectiveness of internet interventions, many studies operationalize adherence only by the number of sessions and do not report adherence to specific treatment components. The goal of this study was to investigate adherence to treatment components as well as outcome in outpatients and self-referred participants who participated in an internet intervention targeting anxiety.Entities:
Keywords: Adherence; Internet interventions; Prediction; Self-referral; Treatment components
Year: 2020 PMID: 32346518 PMCID: PMC7178477 DOI: 10.1016/j.invent.2020.100319
Source DB: PubMed Journal: Internet Interv ISSN: 2214-7829
Fig. 1Flowchart of outpatient participants and self-referred participants.
Baseline variables of participants by group.
| Baseline variables | Overall ( | Outpatient participants (NO = 50) | Self-referred participants (NSR = 37) | Test statistic ( |
|---|---|---|---|---|
| M.I.N.I. diagnosis agoraphobia | ||||
| M.I.N.I. diagnosis social phobia | ||||
| M.I.N.I. diagnosis GAD | ||||
| M.I.N.I. diagnosis panic disorder | ||||
| Sex | ||||
| Level of education | ||||
| Pre- mean score GAD-7 | ||||
| Pre- mean score Mini-SPIN | ||||
| Pre- mean score HSCL-11 | ||||
| Pre- mean score PHQ-9 | ||||
| Treatment expectations | ||||
| Age |
GAD: Generalized Anxiety Disorder.
GAD-7: Generalized Anxiety Disorder Screener-7.
Mini-SPIN: Mini Social Phobia Inventory.
HSCL-11: Hopkins Symptom Checklist-11.
PHQ-9: Patient Health Questionnaire-9.
Adherence to intervention by participant group.
| Variable | Participant group | M (SD)/N | Test statistic | |
|---|---|---|---|---|
| Number of sessions | Outpatient (NO = 50) | 4.48 (2.73) | t(85) = −2.56 | .012* |
| Self-referred (NSR = 37) | 5.95 (5.95) | |||
| All (N = 87) | 5.10 (2.72) | |||
| Adherence to relaxation (N of exercises) | Outpatient (NO = 50) | 4.38 (7.82) | t(85) = −1.96 | .054 |
| Self-referred (NSR = 37) | 8.24 (9.89) | |||
| All (N = 87) | 6.02 (8.01) | |||
| Adherence to exposure (yes) | Outpatient (NO = 50) | 11 (22.0%) | χ2(1) = 4.48 | .034* |
| Self-referred (NSR = 37) | 16 (59.3%) | |||
| All (N = 87) | 27 | |||
| Adherence to cognitive restructuring (yes) | Outpatient (NO = 50) | 16(32%) | χ2(1) = 10.80 | .001* |
| Self-referred (NSR = 37) | 25(50%) | |||
| All (N = 87) | 41(42%) |
*p < 0.05.
Outcome measures at pre and post and effect sizes by participant group.
| Measure | Group | Begin waiting time M (SD) | Pre treatment M (SD) | Post treatment M (SD) | End waiting time M (SD) | Effect-size waiting time Cohens d | Effect-size pre to post Cohens d |
|---|---|---|---|---|---|---|---|
| GAD-7 | Outpatient waitlist (N = 40) | 1.73 (0.82) | 1.60 (0.87) | 0.16 | |||
| Outpatient participants (NO = 50) | 1.78 (0.52) | 2.81 (0.55) | 2.54 (0.72) | 1.65 (0.55) | 0.25 | 0.49 | |
| Self-referred participants (NSR = 37) | 2.75 (0.65) | 2.32 (0.75) | 0.66 | ||||
| All participants (N = 87) | 2.79 (0.59) | 2.44 (0.73) | 0.59 | ||||
| HSCL-11 | Outpatient waitlist (N = 40) | 2.02 (1.06) | 1.85 (1.08) | 0.16 | |||
| Outpatient participants (NO = 50) | 1.91 (0.82) | 2.32 (0.53) | 2.24 (0.59) | 1.71 (0.78) | 0.24 | 0.15 | |
| Self-referred participants (NSR = 37) | 2.19 (0.49) | 1.90 (0.51) | 0.59 | ||||
| All participants (N = 87) | 2.27 (0.52) | 2.10 (0.58) | 0.33 | ||||
| PHQ-9 | Outpatient waitlist (N = 40) | 1.65 (0.64) | 1.42 (0.68) | 0.36 | |||
| Outpatient participants (NO = 50) | 1.36 (0.53) | 2.43 (0.58) | 2.21 (0.58) | 1.37 (0.56) | −0.01 | 0.38 | |
| Self-referred participants (NSR = 37) | 2.13 (0.58) | 1.91 (0.51) | 0.38 | ||||
| All participants (N = 87) | 2.30 (0.59) | 2.09 (0.57) | 0.36 | ||||
| Mini-SPIN | Outpatient participants (NO = 50) | 3.28 (1.08) | 2.83 (0.85) | 0.41 | |||
| Self-referred participants (NSR = 37) | 2.72 (1.04) | 2.19 (0.64) | 0.51 | ||||
| All participants (N = 87) | 3.04 (1.09) | 2.56 (0.83) | 0.44 |
GAD-7: Generalized Anxiety Disorder Screener-7.
40 outpatient participants stayed registered for face-to-face therapy after receiving internet treatment.
HSCL-11: Hopkins Symptom Checklist-11.
PHQ-9: Patient Health Questionnaire-9.
Mini-SPIN: Mini Social Phobia Inventory, only available for participants of the internet intervention.
Fig. 2Mediation model with parallel mediators (n = 87). Indirect effects of participant group through adherence to relaxation, cognitive restructuring, exposure and number of sessions. The direct path from participant group to outcome depicts the direct effect.
Importance by feature as estimated by the LASSO algorithm.
| Adherence to relaxation in outpatient | |
|---|---|
| Feature | Importance |
| Initial impairment FEP2 | 3.06 |
| Self-efficacy GSE | 3.01 |
| Incongruence INC-S | 2.98 |
| Level of education | 2.25 |
| Treatment expectations | 1.97 |
| Sex | 1.00 |
FEP-2: Questionnaire for the Evaluation of Psychotherapeutic Progress (FEP-2).
GSE: General Self-Efficacy Scale.
INC-S: Incongruence Questionnaire – short version.
Baseline variables as predictors of adherence to relaxation in outpatient participants estimated with logistic regression analysis.
| Variables | B (SE) | Lower | OR | Upper | |
|---|---|---|---|---|---|
| Intercept | −5.90(3.84) | .124 | 0.00 | ||
| Initial impairment FEP-2 | 0.90(0.93) | .333 | 0.40 | 2.47 | 15.42 |
| Initial impairment INC-S | −2.56(1.06) | .016 | 0.01 | 0.08 | 0.62 |
| Self-efficacy GSE | 2.49(1.03) | .016 | 1.58 | 12.03 | 91.43 |
| Treatment expectations | 1.31(0.75) | .078 | 0.86 | 3.72 | 16.93 |
| Level of education | 1.53(0.66) | .022 | 1.25 | 4.60 | 16.02 |
Likelihood ratio test χ2= 11.85. p = .037; Nagelkerke R2 = 0.250.
FEP-2: Questionnaire for the Evaluation of Psychotherapeutic Progress (FEP-2).
INC-S: Incongruence Questionnaire – short version.
GSE: General Self-Efficacy Scale.